Quick Take: Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis
Gadolinium-based contrast material is typically used for follow-up imaging of patients with multiple sclerosis (MS) in order to detect new ...
Gadolinium-based contrast material is typically used for follow-up imaging of patients with multiple sclerosis (MS) in order to detect new ...
Association Between the Development of Pediatric Voice Disorders and Singing in Children’s Choir Singing has been thought to be protective ...
Induction of Labor at 41 Weeks Versus Expectant Management Until 42 Weeks (INDEX): Multicenter, Randomized Non-Inferiority Trial It has been ...
1. In this prospective cohort study of patients with multiple sclerosis, upfront use of highly-efficacious disease modifying therapies (DMTs) compared ...
1. In this case-control cohort study, treatment with glatiramer acetate, interferon-beta, fingolimod, alemtuzumab, and natalizumab all led to reduced conversion ...
Secondary progressive multiple sclerosis (SPMS) is the second most common type of multiple sclerosis, a demyelinating syndrome of the central ...
1. In this case-control cohort study, treatment with glatiramer acetate, interferon-beta, fingolimod, alemtuzumab, and natalizumab all led to reduced conversion ...
An Evaluation of the Effects of Lowering Blood Alcohol Concentration Limits for Drivers on the Rates of Road Traffic Accidents ...
1. Rituximab was associated with lower discontinuation rates as compared to other disease-modifying treatments in newly diagnosed patients with relapsing-remitting ...
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia In 2014, two candidate Ebola virus (EBOV) vaccines ...
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free · only $4.16/month
Then $49.90/year. Manage renewal in your account.
Already a member? Sign in